These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
331 related items for PubMed ID: 15630031
21. Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows. Scaglione L, Piobbici M, Pagano E, Ballini L, Tamponi G, Ciccone G. Haematologica; 2005 May; 90(5):678-84. PubMed ID: 15921383 [Abstract] [Full Text] [Related]
22. [Low molecular weight heparin--a safer anticoagulant in thrombosis and cancer]. Schulman S. Lakartidningen; 2004 May 06; 101(19):1712-5. PubMed ID: 15188585 [No Abstract] [Full Text] [Related]
23. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke? Kamphuisen PW, Agnelli G. Thromb Res; 2007 May 06; 119(3):265-74. PubMed ID: 16674999 [Abstract] [Full Text] [Related]
24. Prevention of venous thromboembolism in patients. Hairon N. Nurs Times; 2007 May 06; 103(18):23-4. PubMed ID: 17508658 [No Abstract] [Full Text] [Related]
25. Is low-molecular-weight heparin safer than warfarin for secondary prevention of venous thromboembolism in cancer patients? Caine GJ, Lip GY. Arch Intern Med; 2003 May 26; 163(10):1243-4; author reply 1244. PubMed ID: 12767973 [No Abstract] [Full Text] [Related]
26. The optimal long-term treatment of venous thromboembolism. Prandoni P. Clin Adv Hematol Oncol; 2004 Nov 26; 2(11):729-32. PubMed ID: 16170889 [No Abstract] [Full Text] [Related]
27. Letter 1: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344). Wille-Jorgensen P. Br J Surg; 2006 Mar 26; 93(3):374; author reply 375-6. PubMed ID: 16498577 [No Abstract] [Full Text] [Related]
29. Letter 3: meta-analysis of trials comparing ximelagatran with low molecular weight heparin for prevention of venous thromboembolism after major orthopaedic surgery (Br J Surg 2005; 92: 1335-1344). Agnelli G, Bergqvist D, Dahl O, Eriksson B, Rud Lassen M, Mouret P, Rosencher N. Br J Surg; 2006 Mar 26; 93(3):375; author reply 375-6. PubMed ID: 16498579 [No Abstract] [Full Text] [Related]
31. Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials. Wein L, Wein S, Haas SJ, Shaw J, Krum H. Arch Intern Med; 2007 Jul 23; 167(14):1476-86. PubMed ID: 17646601 [Abstract] [Full Text] [Related]
32. [Prevention of venous thromboembolism in internal medicine and neurology]. Malý J, Dulícek P, Penka M, Malý R, Gumulec J. Vnitr Lek; 2006 Mar 23; 52 Suppl 1():63-7. PubMed ID: 16637452 [Abstract] [Full Text] [Related]
39. [Prevention and treatment of venous thromboembolism in patients with cancer]. Struve S, Wendtner CM. Dtsch Med Wochenschr; 2012 Oct 19; 137(40):2007-9. PubMed ID: 22987155 [No Abstract] [Full Text] [Related]
40. [Deep venous thrombosis--treatment]. Fries R, Böhm M. Dtsch Med Wochenschr; 2003 May 02; 128(18):999-1002. PubMed ID: 12721879 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]